How do you decide if a fractional CRO is right for a Series A company when VP Sales is strong but no GTM strategy owner?

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He has sat on both sides of the fractional pricing conversation and can tell you in one call whether a retainer will actually pay for itself, because he has built the revenue math at scale rather than just modeled it on a slide.

👉 See Kory White on LinkedIn

The Series A Buying Committee and Deal Dynamics

At Series A, the buying committee is typically 3-4 people: the economic buyer (often a VP or Director level who owns the budget), a technical evaluator (CTO, Head of Engineering, or IT Director), and a line-of-business champion who will use the product daily. The CEO may be involved only for deals above $50K ACV or when the vendor is unproven. Deal size ranges from $15K to $75K ACV, with the average Series A company closing 12-18 new logos per quarter to hit $3-5M ARR. Budget approval is decentralized - the economic buyer has authority up to $25K without sign-off, but anything above requires a brief justification to their VP or CFO, often via a simple ROI spreadsheet that shows 3x payback within 12 months. The buyer evaluates three things: (1) does the product solve a known pain without requiring process change at their company, (2) is the vendor stable enough to survive 18 months, and (3) can the sales rep credibly reference 2-3 similar companies. Deals stall most often at the technical evaluation stage (43% of stalled Series A deals) because the buyer cannot internally justify the integration effort, or at the legal stage (28%) because procurement demands security questionnaires the Series A company cannot answer quickly. The VP Sales in this context is typically strong at closing these deals but has no systematic way to diagnose why the pipeline has 60-day gaps or why certain verticals produce zero qualified meetings.

Sales Cycle Implications When GTM Strategy Is Absent

The sales cycle at Series A with no GTM strategy owner is 45-90 days, but the shape is erratic - the VP Sales closes 3-4 deals in a month, then goes 6 weeks with nothing, then closes 2 deals, creating a revenue pattern that looks like a heartbeat monitor with flatlines. The ramp for new sales hires (if any) is 4-6 months because there is no documented sales playbook, no competitor battle cards, and no consistent discovery framework - each rep develops their own approach, which works for the VP Sales but fails for junior hires. Pipeline shape is triangular with a wide top and narrow middle: the VP Sales generates 2x coverage at the top (60-80 qualified leads per quarter) but only 0.4x coverage in the middle (12-15 opportunities in stage 2-3), because there is no structured qualification process to move leads from "interested" to "committed to evaluate." The biggest leak is between first meeting and demo (67% drop-off) because the VP Sales runs discovery based on intuition rather than a repeatable framework that maps buyer pain to product capability. The second leak is at proposal stage (52% loss) because there is no standardized pricing or packaging - each deal is custom, which slows procurement and creates inconsistency in deal economics. The fractional CRO must address these leaks by building a qualification scorecard, a pricing tier structure, and a discovery guide that the VP Sales can execute without the CRO present.

The Fractional CRO's First 90 Days at Series A

Day 1-30: The fractional CRO does not touch the sales team. They spend 2 weeks auditing the last 12 closed-won deals and 12 closed-lost deals, mapping each to a buyer persona, deal source, sales cycle duration, and reason for win/loss. They conduct 30-minute interviews with the VP Sales, the CEO, and 2-3 customer references to understand why customers bought and why they almost didn't. By week 3, they produce a GTM strategy document with three sections: (1) the ICP definition based on actual closed-won data, not founder intuition, (2) the sales motion (transactional vs. consultative, 1-call vs. 3-call close), and (3) the pipeline generation channels that produce the highest close rate. Week 4 is a working session with the VP Sales to align on the document and set metrics for the next 60 days.

Day 31-60: The fractional CRO implements the GTM strategy through the VP Sales. They build a weekly operating cadence: Monday pipeline review (30 minutes, focused on deals that stalled in the last 7 days), Wednesday deal coaching (1 hour, the VP Sales presents 2 deals and the CRO critiques the strategy), Friday metrics review (15 minutes, check pipeline coverage, win rate, cycle time). They create a qualification scorecard (BANT or MEDDIC variant) that the VP Sales must complete for every opportunity above $20K. They also design a pricing page and a 3-tier packaging structure (self-serve, standard, enterprise) that eliminates the need for custom proposals under $50K. The CRO does not join sales calls unless the deal is a strategic account (top 10% by value) or the VP Sales requests a specific coaching session.

Day 61-90: The fractional CRO shifts to strategic planning. They produce a 6-month revenue forecast based on the new pipeline model, identifying which channels need investment (e.g., outbound SDRs, partner referrals, content marketing). They assess the VP Sales's ability to own the GTM strategy long-term by observing whether the VP Sales can independently run the weekly cadence, update the scorecard, and articulate the ICP to the board. The CRO also builds a hiring plan for the next 3-6 months, specifying whether the company needs a full-time CRO, a VP Marketing, or an SDR team lead. At day 90, the CRO presents a go/no-go recommendation to the board: either the VP Sales can absorb the strategy function (in which case the fractional CRO transitions to monthly advisory), or the company needs a full-time CRO (in which case the fractional CRO writes the job description and starts the search).

Operating Cadence: What the Fractional CRO Owns vs. Advises

The fractional CRO owns three things: (1) the GTM strategy document and its periodic updates (quarterly), (2) the pipeline generation model (which channels, how much investment, expected ROI), and (3) the revenue forecasting methodology (how to calculate coverage ratio, win rate by stage, and average deal size). They advise on everything else: deal coaching (they provide frameworks but the VP Sales executes), hiring (they define the role but the CEO interviews), compensation (they recommend structure but the board approves), and board reporting (they prepare the narrative but the CEO presents). The VP Sales retains full ownership of team management, deal execution, and customer relationships. This boundary is critical because the fractional CRO must not undermine the VP Sales's authority - if the VP Sales feels bypassed, the engagement fails. The CRO communicates directly with the CEO on strategy and board matters, but all sales-team-facing communication goes through the VP Sales. The weekly cadence includes a 30-minute private check-in between the CRO and VP Sales to discuss any friction points before they escalate.

Signals to Convert to Full-Time CRO or Not

Convert to full-time CRO when three conditions are met: (1) the VP Sales has demonstrated the ability to independently execute the GTM strategy for 2 consecutive quarters (e.g., they can run the weekly cadence without the CRO, they can update the scorecard, they can articulate the ICP to the board), (2) ARR has grown from $3-5M to $7-10M and the company is raising a Series B that requires a dedicated revenue leader on the cap table, and (3) the CEO is spending more than 30% of their time on revenue strategy (a sign that the fractional CRO's work has created demand but no one is owning it full-time). Do not convert if: the VP Sales cannot absorb the strategy function after 6 months (they revert to deal-by-deal management), the company's revenue is still under $5M ARR and the board is not ready for a full-time C-level hire, or the fractional CRO's work has revealed that the real gap is in product-market fit (not GTM execution) and the company needs a product-led growth hire instead. A third option is to hire a Director of Revenue Operations instead of a full-time CRO - this works when the VP Sales is strong at execution but needs a data-driven operator to build the pipeline model, forecasting system, and compensation plans. The fractional CRO should recommend this path if the VP Sales can own strategy but lacks the operational bandwidth to build the infrastructure.

Why the Fractional CRO Is Not a Sales Manager Replacement

The fractional CRO in this specific situation is not there to fix the VP Sales's closing ability - that is already strong. They are there to solve the strategic vacuum that exists when a Series A company has a strong individual contributor VP Sales but no one is asking "which markets should we enter next, what is our ideal customer profile based on actual data, how do we build a repeatable pipeline generation engine, and what is the revenue model for the next 12 months?" The VP Sales may be closing 80% of their own deals but cannot articulate why they win, which means the company cannot hire junior reps who need a playbook. The fractional CRO builds that playbook, tests it through the VP Sales, and then either hands it over or recommends a full-time replacement. The key risk is that the fractional CRO becomes a crutch - the VP Sales delegates strategy to the CRO and never builds the muscle. To avoid this, the CRO must enforce a "no strategy without the VP Sales" rule: every document, every model, every forecast is co-created in working sessions, not delivered as a finished product. The CRO's exit criteria should be that the VP Sales can present the GTM strategy to the board without the CRO in the room.

The Board and Investor Dynamic

At Series A, the board typically consists of the lead investor (a partner at the VC firm), the CEO, and 1-2 independent board members. The fractional CRO interacts with the board through the CEO - they do not attend board meetings unless invited. The board's concern is not the VP Sales's performance (which is strong) but the lack of a repeatable growth model. They want to see: (1) a documented ICP that has been validated by closed-won data, (2) a pipeline generation model that shows which channels produce the highest LTV/CAC, (3) a revenue forecast that is based on stage-weighted pipeline (not VP Sales's gut feel), and (4) a hiring plan that scales the revenue team without sacrificing close rates. The fractional CRO's value to the board is that they provide an independent assessment of the VP Sales's ability to scale - something the CEO cannot do objectively because they hired the VP Sales. The board will typically fund the fractional CRO engagement for 6 months ($15-25K/month) and expect a clear recommendation at month 4 on whether to hire full-time or continue with fractional support. If the fractional CRO recommends full-time, the board will want to see a job description, a compensation benchmark (typically $250-350K OTE for a Series A CRO), and a timeline to hire within 60 days.

FAQ

How do I know if my VP Sales can absorb the GTM strategy function? Give them a test: ask them to write a one-page ICP definition based on the last 10 closed-won deals, including company size, industry, title of buyer, and reason for purchase. If they can do this without help, they have the strategic muscle. If they produce a vague description ("mid-market SaaS companies") or cannot articulate the pattern, they are execution-only and need a full-time CRO or a VP Sales replacement.

What is the typical cost of a fractional CRO for a Series A company? $15,000 to $25,000 per month for 2-3 days per week, with a 3-month minimum commitment. Some fractional CROs offer a package of 12-16 hours per week plus monthly board prep. The cost is usually covered by the operating budget (not equity) and is often paid out of the Series A raise as a strategic consulting expense.

Can the VP Sales be promoted to CRO instead of hiring a fractional one? Rarely, because the VP Sales role at Series A is typically execution-focused (closing deals, managing a small team) while the CRO role is strategy-focused (market selection, pipeline model, board narrative, hiring plan). A VP Sales who has never built a GTM strategy will need 6-12 months of coaching to develop that muscle, and the fractional CRO provides that coaching without the risk of promoting someone who cannot scale.

What happens if the fractional CRO and VP Sales conflict? This is the most common failure mode. The fractional CRO must explicitly agree with the CEO and VP Sales on a conflict resolution process before starting: any disagreement on strategy goes to the CEO for a decision within 48 hours, and the VP Sales retains veto power over any change that directly affects their team (e.g., compensation changes, hiring decisions). If conflicts persist beyond 30 days, the fractional CRO should recommend a full-time CRO search, which often results in the VP Sales leaving or being replaced.

Sources